Quantitative determination of fexofenadine in human plasma by UPLC

Indian Journal of Pharmaceutical Education and Research

Volumn 44, Issue 3, 2010, Pages 295-300

  Jain, Deepak Kumar ^a   Kumar, Amin Maulik ^b   Jain, Deepti ^a  

^a School of Pharmaceutical Science   (India)

^b Cadila Pharmaceutical Ltd   (India)

Author keywords

Fexofenadine; Human plasma; Liquid liquid extraction; UPLC

Indexed keywords

ACETIC ACID ETHYL ESTER; ACETONITRILE; CARBAMAZEPINE; FEXOFENADINE; POTASSIUM DIHYDROGEN PHOSPHATE;

ACCURACY; ARTICLE; BIOEQUIVALENCE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG ISOLATION; DRUG STABILITY; DRUG STRUCTURE; ELUTION; FLOW RATE; HUMAN; HUMAN TISSUE; QUALITY CONTROL; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; STANDARD; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 77957356458     PISSN: 00195464     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Williams DA, Lemke TL. Foyès principle of medicinal chemistry. 5 th ed. Varghese Publishing House Bombay, 2002, 304.
2. Simpson K, Jarvis B. Fexofenadine: A review of its use in the management of seasonal allergic rhinitis a nd chronic idiopathic urticaria. Drugs 2000;59:301-321.
3. Radhakrishna T, Om Reddy G. Simultaneous determination of fexofenadine and its related compounds by HPLC. J Pharm Biomed Anal 2002; 29: 681-690.
4. Nirogi RV, Kandikere VN. Shukla M, Mudigonda, K, Komarneni P. Simultaneous quantification of fexofenadine and pseudoephedrine in human plasma by l iquid chromatography/ tandem mass spectrometry with electrospray ionization, method development, validation and application to a clinical study. Rapid Commun Mass Spectrom 2006; 20:3030-8.
5. Breier AR, Paim CS, Menegola J, Steppe M, Schapoval EE. Development and validation of a liquid chromatographic method for fexofenadine hydrochloride in capsules. J Pharm Sci 2004; 7:1093-7.
6. Hofmann U, Seiler M, Drescher S, Fromm MF. Determination of fexofenadine in human plasma and urine by liquid chromatography-mass spectrometry. J Chromatogr B 2002; 766: 227-33.
7. Uno T, Yasui-Furukori N, Takahata T, Sugawara K, Tateishi T. Liquid chromatographic determination of fexofenadine in human plasma with flurescence detection. J Pharm Biomed Anal 2004; 35: 937-42.
8. Miura M, Uno T, Tateishi T, Suzuki T.Determination of fexofenadine enantiomers in human plasma with HPLC. J Pharm Biomed Anal 2007; 43: 741-5.
9. Fu I, Woolf EJ, Matuszewski BK. Determination of fexofenadine in human plasma using 96-well solid phase extraction with HPLC with tandem mass specttrometric detection. J Pharm Biomed Anal 2004; 35: 837-46.
10. Leandro CC, Hancock P, Fussell RJ, Keely BJ. Compar ison of ul t ra-per formance l iquid chromatography and high-performance liquid Ch omatography for the determination of priority pesticides in baby foods by tandem quadrupole mass spectrometry. J Chromatogr A 2006; 1103: 94-101.
11. Churchwell MI, Twaddle NC, Meeker LR, Doerge DR. Improving LC-MS sensitivity through increases in chromatographic performance: Compar i sons of UPLC- ES/MS/MS to HPLC-ES/MS/MS. J Chromatogr B 2005; 825:134-142.
12. US Department of Health and Human Services, Food and Drug Administration, Guidance for Industry Bioanalytical Method Validation (2001)http://www.fda.gov/cder/guidance/ 4252fnl.pdf.
13. International Conference on Harmonization, Draft Guideline on Validation Procedures Definitions and Terminology, Federal Register, vol. 60, IFPMA, Switzerland, 1995, pp. 11260- 11266.